Abstract Schistosomes are parasitic platyhelminths that currently infect over 200 million people and cause the chronic debilitating disease schistosomiasis. While these large intravascular parasites can disturb blood flow, surprisingly they do not appear to provoke thrombus formation around them in vivo. In order to determine if the worms can alter their local environment to impede coagulation, we incubated adult worms (50 pairs) in murine blood (500 ll) for 1 h at 37°C and, using thromboelastography (TEG), we compared the coagulation profile of the blood with control blood that never contained worms. Substantial differences were apparent between the two profiles. Blood that had been exposed to schistosomes clotted more slowly and yielded relatively poor, though stable, thrombi; all TEG measures of blood coagulation (R, K, a-angle, MA, G and TMA) differed significantly between conditions. No fibrinolysis (as determined by LY30 and LY60 values) was detected in either case. The observed TEG profile suggests that the worms are acting as local anti-coagulants. Blood recovered from schistosomeinfected mice, however, does not behave in this way. At an early time point post infection (4-weeks), the TEG profile of infected murine blood is essentially the same as that of control blood. However at a later time point (7-weeks) infected murine blood clots significantly faster than control blood but these clots also break down faster. The R, K, aangle, and TMA measures of coagulation are all significantly different between the control versus infected mice as are the LY30 and LY60 values. This profile is indicative of a hypercoagulable state with fibrinolysis and is akin to that seen in human patients with advanced schistosomiasis.
Introduction
Schistosomes are parasitic platyhelminths that currently infect over 200 million people and cause the chronic debilitating disease schistosomiasis (or bilharzia) [1, 2] . People become infected when free-swimming larval forms called cercariae penetrate the skin. Here the larvae transform into the intra-mammalian life forms called schistosomula. Schistosomula invade a blood vessel and migrate over several weeks through the heart and lungs to the hepatic vasculature where they mature into adult males and females. At about 4-weeks post infection, males and females pair and paired Schistosoma mansoni couples then migrate to the mesenteric venules. Adult female worms release hundreds of eggs daily and many of these are eliminated from the body with feces. In freshwater, ciliated forms called miracidia hatch from the eggs to infect a suitable snail host. Within the snail, asexual replication occurs leading to the generation of the larval forms mentioned earlier (cercariae) that infect humans to complete the life cycle.
The symptoms of schistosomiasis are caused not so much by the parasites themselves but by the reaction of the host to worm eggs that do not exit the body [3] . Eggs shed by adult worms that are not eliminated can become lodged in the liver, intestine, bladder or other organs, where they evoke an intense immunological reaction causing inflammation or scarring [3] . While schistosome eggs elicit this strong immune response, at the same time no overt cellular immune response can be detected around the source of those eggs-the adult worms in the vasculature [4] . Indeed the worms appear to provoke little if any damaging response not just from the host's immune system but also from the hosts hemostatic system [5] . Adult schistosomes are relatively large (*0.5 mm in diameter and up to 10 mm long) in comparison to the size of the veins in which they commonly reside. Obstructions in blood vessels, such as those caused by schistosomes, should lead to disturbances of blood flow. This situation predisposes to thrombotic complications [6] . While the worms have been proposed to possess a variety of molecular mechanisms that might impede coagulation, whether the worms can actually alter their local blood environment to block coagulation has not been directly monitored. One objective of this work is to determine if adult schistosomes ex vivo can alter the clotting properties of murine blood. An additional objective is to determine the coagulation properties of blood from schistosome-infected mice at 4-versus 7-weeks post infection. To test the efficiency of coagulation in this work, we employ thromboelastography (TEG)-a hemostatic assay that measures the global viscoelastic properties of whole blood-clot formation under low shear stress [7] . To perform TEG, a wire probe is inserted into a blood sample which is gently rotated at an angle. The motion of the probe, which varies as a blood clot forms, is displayed graphically. The speed and strength of blood clot formation around the probe are measured as is the rate of breakdown of formed clots. We use TEG in this work to compare the impact of schistosomes versus schistosomiasis on the properties of whole murine blood coagulation and blood clot lysis.
Methods Parasites
Snails were provided by the Schistosome Research Reagent Resource Center for distribution by BEI Resources, NIAID, NIH: Schistosoma mansoni, strain NMRI exposed Biomphalaria glabrata snails, strain NMRI, NR-21962.
Mice
Cercariae, obtained from infected B. glabrata, were used to infect 6-to 8-week-old, female CD-1 strain mice (at *125 cercariae/mouse) via the tail exposure method [8] . Blood was collected from the tail veins of control or infected mice at 4-weeks and at 7-weeks post infection in tubes containing buffered sodium citrate (BD Biosciences). Blood was pooled from each group of 3 mice to ensure sufficient volumes for analysis. Adult male and female parasites were recovered by vascular perfusion from the mice at 7-weeks post infection and were cultured in complete DMEM/F12 medium supplemented with 10 % heat-inactivated fetal bovine serum, 200 U/ml penicillin and 200 lg/ml streptomycin, 0.2 lM Triiodo-L-thyronine, 1.0 lM serotonin and 8 lg/ml human insulin. Parasites were maintained at 37°C, in an atmosphere of 5 % CO 2 . Work with animals was approved by the Tufts University IACUC; protocol number: G2012-150.
Thromboelastography (TEG)
To investigate the ex vivo effect of schistosomes on the coagulation properties of mouse blood, approximately 50 adult worm pairs (after being maintained for one week in culture) were washed several times briefly with PBS, and were then incubated in 500 ll of fresh, citrated normal murine blood at 37°C in an atmosphere of 5 % CO 2 for one hour. Control blood was similarly treated but without parasites. Thereafter worms were removed using a 100 lm cell strainer (BD Biosciences) and blood (final volume: 340 ll) was placed into the sample cup of a TEG machine (Hemoscope Corporation, Niles, IL). To initiate coagulation, 20 ll of 0.2 M calcium chloride was added and samples were subjected to TEG analysis at 37°C using the ''Citrated Native'' protocol, as described [7] . To monitor the impact of parasite infection on the coagulation properties of infected animals, blood was collected from control and infected mice at 4-and 7-weeks post infection as described above and subjected to TEG analysis.
Statistics
Differences in the mean measurements between two groups were assessed for statistical significance using the twotailed student's t test; P values of \0.05 were considered significant.
Results
The coagulation profile of blood obtained from control mice versus blood from infected mice at 7-and 4-weeks post infection A representative TEG waveform obtained using blood collected from an uninfected, control mouse is shown in Fig. 1a (black line) . This is compared to a TEG tracing derived using blood collected from a schistosome-infected mouse, 7-weeks post-infection (Fig. 1a , grey line marked ''infected''). The two sample tracings are starkly different. Figure 1b illustrates the various measurements that can be obtained from TEG tracings like the one shown in Fig. 1a . Table 1 records the values obtained (mean ± SD, n C 7) using blood from control (top panel) versus infected (middle panel) mice. These measures include the speed of initial clot formation (reaction time, R); the time from the end of R until the clot reaches 20 mm (K value, a measure of clot progression); a-angle (the tangent of the curve at 2 mm amplitude) is a measure of the rate of clot formation; MA is maximum amplitude, a reflection of clot strength; TMA is the time it takes for the clot to reach maximal amplitude and the G value is a measure of clot strength. These parameters all relate to the process of blood clot formation (coagulation) whereas the remaining parameters (LY30 and LY60) are measures of blood clot dissolution (fibrinolysis). LY30 is the measure of percent clot lysis 30 min after MA is reached and LY60 is percent lysis at 60 min. The level of any statistically significant difference (P value) between infected and control groups is presented in the bottom panel of Table 1 for each measurement.
For most of the measurements, blood from infected animals behaves significantly differently compared to blood from control animals in this assay. The R, K, aangle, and TMA measures of coagulation are all significantly different between the control versus infected mice (P = 0.04-0.001). For R, K and TMA, the infected plasma values are all *60 % of the control values. Of the coagulation measures recorded, only MA and G do not differ significantly between infected and control groups Fig. 1 The coagulation profile of blood obtained from control mice versus blood from schistosome-infected mice at 7-weeks post infection. a A representative TEG tracing obtained using blood collected from an uninfected, control mouse (black line) is depicted alongside the starkly different tracing derived using blood collected from a schistosome-infected mouse, 7-weeks post-infection (grey line, ''infected''). b A schematic TEG tracing highlighting the various measurements that can be derived from TEG tracing data Table 1 Parameters of coagulation obtained by thromboelastography from the blood of control mice versus the blood of schistosome-infected mice at 7-weeks (A) and 4-weeks (B) post infection A 7-weeks post infection The values obtained (mean ± SD, n C 7) following TEG are summarized for control (top panels) versus infected (middle panels) groups; the level of any statistically significant difference (P value; two-tailed t test) between the groups is presented in the bottom panel for each measurement
NS not significant
The impact of schistosomes and schistosomiasis on murine blood coagulation and fibrinolysis… 673 (P [ 0.4). The degree of fibrinolysis also differs significantly between the groups at both the 30 min time point (LY30) and at the 60 min time point (LY60). The mean percent lysis for the blood from infected animals is close to 5 % at 30 min and close to 10 % at 60 min whereas control blood clots remain essentially intact (0 % lysis). The TEG profile of 7-week infected mice can be summarized as indicative of a hypercoagulable state with enhanced fibrinolysis. This condition is akin to the clinical condition known as disseminated intravascular coagulation (DIC) [9] . The same analysis was conducted on blood from all of these mice earlier in the infection process-at 4-weeks post-infection, and the values obtained are presented in Table 1B 
The coagulation profile of control murine blood versus murine blood that contained adult schistosomes ex vivo
In order to determine what direct effect (if any) schistosome parasites have on murine blood that might impact its ability to coagulate, 50 pairs of adults were first incubated in 500 ll of fresh citrated blood for 1 h at 37°C. Next, the worms were removed and the TEG profile of the blood was compared with that of control murine blood incubated for 1 h at 37°C but without parasites. Figure 2 shows a representative TEG tracing derived using control blood (black line) compared to a representative TEG tracing derived using blood that previously contained schistosomes (grey line marked ''? parasites''). Substantial differences are apparent between the two tracings. The standard TEG measurements (mean ± SD, n = 4) are reported in Table 2 for control blood (top panel) versus blood that contained parasites (middle panel, ''plus parasites''); the level of any statistically significant difference (P value) between the groups is presented in the bottom panel for each measurement. All measures of blood coagulation (R, K, a-angle, MA, G and TMA) differ significantly between conditions (P = 0.04-0.003) whereas no fibrinolysis (as determined by LY30 and LY60 measurement) is detected in either case. Clinically this pattern is most commonly seen in patients with hemophilia or those on anti-coagulant therapy [9] .
Discussion
In this work we measured the coagulation profiles of blood from control mice and from schistosome-infected mice at 4-and 7-weeks post infection. At the 4-week time point there is no significant difference in the coagulation profiles of blood from infected mice compared to those of uninfected control mice. However, by 7 weeks post infection, the situation has drastically changed; in most of the coagulation parameters measured by thromboelastography, blood from infected mice behaves significantly differently from that of uninfected controls. Infected blood takes a shorter amount of time to begin to clot (R value); clot formation progresses more rapidly (with a lower K value and a larger a-angle) such that the time to maximal clot amplitude (TMA) is considerably shorter for infected versus control blood. However, the clots that form in either case (from infected or control blood) do not differ significantly in strength (as determined by their mean MA and G values). A further striking difference is that while clots derived from control blood are very stable (essentially no fibrinolysis is observed over the course of the experiment), clots generated from blood obtained from 7-week infected mice, in contrast, begin to break down rapidly. In essence, blood from schistosome infected animals (at 7-weeks post infection) clots very rapidly but those clots also lyse rapidly. In contrast, blood taken from schistosome infected animals at an earlier time point post-infection (at 4-weeks), like control blood from uninfected animals, clots more slowly and these clots are stable. What accounts for the different clotting profiles of the blood of 4-versus 7-week infected mice? One substantial difference is that at about 4-weeks post infection schistosomes reach maturity; adult males and females form pairs and begin to lay eggs. While many of these eggs exit the body of the host to continue the parasite's life cycle, many more get caught in the blood stream of the host and are swept to the vascular beds of surrounding tissues. Since the adult worms reside largely in Fig. 2 The coagulation profile of control murine blood versus murine blood that previously contained adult schistosomes. A representative TEG tracing derived using control blood (black line) is compared to the starkly different tracing derived using blood that previously contained schistosomes (grey line, ''?parasites'', 50 adult pairs in 500 ll at 37°C for 1 h) the mesenteric venules, eggs that do not make it out of the host often get passively transported in the blood flow to the liver where they are trapped. An intense anti-egg immune response leads to each egg being surrounded by an array of immune cells to form an encapsulating structure known as a granuloma [3] . The primary pathological consequences of schistosome infection are the host's immune response to these parasite eggs within host tissues [3] . Severe pathological changes associated with granuloma formation can affect multiple organ systems but particularly the liver and spleen. This means that at 4 weeks post infection murine hosts experience relatively little overt pathology (at least at the level of parasite infection used here) since the worms have only just matured and no to few eggs have yet been laid. In contrast, at the 7-week time-point, each adult couple has been laying eggs for weeks (hundreds per day) and considerable organ pathology is evident. Since the liver is the primary site of synthesis of many coagulation factors, any impairment of its function can impinge upon the process of blood coagulation. This also seems to be the case in human schistosomiasis: an analysis of blood from 55 patients with more advanced disease manifestation (hepatoslenic schistosomiasis) confirms that hemostatic abnormalities in these patients are associated with increased liver fibrosis, reduced liver function [10] and reduced blood coagulation factor levels [11] . A study of 14 patients (also with hepatosplenic schistosomiasis) likewise revealed that all coagulation parameters were significantly reduced in this group compared to healthy controls [11] . In another study, the coagulation profile of 60 schistosomiasis patients, with hepatosplenomegaly whose liver disease was graded least to worst, was compared with 15 healthy controls [12] . It was reported that the progressive deterioration of liver function (matching the severity of the disease and the intensity of infection) led to a reduction in the blood levels of numerous coagulation proteins resulting in hypercoagulability and thrombin generation. This was subsequently followed by coagulation factor consumption, resulting in hypocoagulability and secondary fibrinolysis [12] . This last outcome is broadly akin to what is observed in this work: blood from 7-week infected mice forms strong clots much more rapidly than blood from controls but these clots are prone to break down very rapidly.
Perhaps contributing to the clotting abnormalities detected in schistosomiasis patients is the diminution in total platelet numbers (thrombocytopenia) that can accompany infection. In humans with portal hypertension due to schistosomiasis, platelet levels are about half those of uninfected controls [13] . In schistosome-infected mice too there is a reduction in total platelet numbers as the infection progresses [14] . Overall, it thus appears that having lower levels of coagulation control proteins in the blood promotes rapid clotting of blood (in the case of 7-week infected mice and human patients with hepatosplenic disease). However this may be counterbalanced by lower blood platelet numbers as well as lower levels of fibrinolysis control constituents, all of which may lead to the rapid dissolution of these clots. We cannot unambiguously determine whether the hyperfibrinolysis detected is solely due to DIC and endogenous plasmin activity or whether some schistosome activity contributes to this.
Another major finding of this work is that the impact of schistosome parasites themselves on blood and subsequent blood clotting is entirely distinct from the impact of the disease schistosomiasis on blood clotting, as just described. Blood from 7-week infected mice clots rapidly and lyses rapidly. Not so for blood in which schistosome parasites were incubated for 1 h. This blood takes longer to clot and the clots do not lyse. After adult worms have been incubated in blood for 1 h, the coagulation profile of that blood differs significantly from that of control blood. The TEG pattern observed is akin to that seen in patients with hemophilia or who are taking anticoagulants [9] . Thus, it appears that schistosomes act as local anti-coagulants.
The worms have been reported to possess several molecular mechanisms that might be responsible for the anticoagulant, clotting defects measured here. For instance, a schistosome surface ATP-diphosphohydrolase enzyme (designated Sm ATPDase1) [15, 16] can cleave exogenous ADP-an important pro-thrombotic platelet activator [17] . The values obtained (mean ± SD, n = 4) following TEG are summarized for control blood (top panel) versus blood that previously contained 50 adult schistosome pairs in 500 ll at 37°C for 1 h (middle panel, Plus Parasites). The level of any statistically significant difference (P value, t test) between the groups is presented in the bottom panel for each measurement
The impact of schistosomes and schistosomiasis on murine blood coagulation and fibrinolysis… 675 which may block platelet activation and blood clot formation, as observed here [18] . The tegumental protein Sm22.6, in recombinant form, can inhibit the proteolytic activity of thrombin, a central component in the coagulation cascade [19] . A schistosome homolog (designated SHW 4-2) of the host anti-coagulation protein antithrombin might also bind and inhibit thrombin, in addition to other coagulation cascade proteases [20] , to block blood clot formation. While this protein has been immunolocalized to adult worm peripheral tissues [20] , it has not been identified in any of the surface tegument proteomic analyses [21] [22] [23] so whether SHW 4-2 could directly contact host blood proteins like thrombin is unclear. Thrombin might additionally be targeted for inhibition by schistosome tegumental glycans; worm tegument fractions have been shown to possess heparin-like glycosaminoglycans (GAGs) [24] which could conceivably act as heparin does-by binding host antithrombin to inactivate thrombin (and other coagulation proteases) and impede coagulation. However, as for SHW 4-2, whether the identified worm GAGs are exposed to the host (and thus capable of performing their hypothesized function) has not been proven. Finally, schistosomes have been reported to be able to generate and release prostaglandins [25, 26] including PGD 2 which is a potent inhibitor of platelet aggregation [27] . Some or all of these effects may be responsible for the dysfunction imposed on normal murine blood by schistosomes as reported here. Schistosomes may act not only to impede blood clot formation but also to promote the breakdown of any blood clots that do form. Schistosoma bovis tegument extracts contain several plasminogen-binding proteins including enolase and annexin [28] . In recombinant form these proteins bind plasminogen and increase its conversion to plasmin in the presence of tissue plasminogen activator [29] . By cleaving fibrin, plasmin plays a central role in the degradation of blood clots [30] . In our experiments involving blood that previously contained schistosomes, blood clot lysis was not detected. The blood clots that formed were as stable as those formed from control blood. This result is not surprising since the worms were removed prior to clotting analysis and for the surface plasminogen binders to exert their effects, the worms (and their surface plasminogen-activating proteins) would need to be still present.
Other proposed methods of schistosome-induced dampening of coagulation include the action of a parasite kallikrein-like enzyme which may cleave the plasma protein kininogen to generate the small vasoactive peptide bradykinin [31] . Bradykinin can trigger the release of the platelet degranulation inhibitor prostacyclin (PGI 2 ) from endothelial cells [32] . An additional role of heparin is to stimulate the release of the protein Tissue Factor Pathway Inhibitor (TFPI) from the endothelium. TFPI inhibits coagulation factor Xa and the TFPI-Xa complex can bind to the Tissue Factor (TF)-coagulation factor VIIa complex (TF-VIIa), further inhibiting coagulation. Conceivably the schistosome GAGs mentioned above could also exert these TFPI effects to block coagulation. However, these indirect effects can have no bearing on the coagulation inhibition monitored in this work since no endothelial cells (upon which schistosome-derived molecules could act) are present in this experimental set-up.
In summary, the work presented here shows that schistosomes exert a strong influence on the biochemistry of their local environment. Understanding how the worms modulate blood coagulation properties as reported here could perhaps be exploited to generate therapeutic options for blood disorders beyond schistosomiasis.
